Key result
Perindopril treatment for 12 weeks reduced mean sitting blood pressure from 156.9/94.5 to 139.2/84.0 mm Hg, with 48.8% of patients achieving blood pressure control.
Why the study?
Does perindopril reduce blood pressure in US hypertensive patients?
Does perindopril reduce blood pressure in US hypertensive patients?
Perindopril effectively lowers blood pressure in a large, real-world community setting, highlighting its utility despite suboptimal physician adherence to hypertension guidelines.
Answers are grounded in this paper and cite their sources.
Supports perindopril for BP lowering in US patients; extends real-world cohort data but leaves open need for randomized confirmation.
The authors evaluated, in a community-based open-label trial, the effectiveness and safety of perindopril in 13,220 US hypertensive patients and studied how physicians adhere to hypertension treatment guidelines. Patients received perindopril 4 mg q.d. for 6 weeks. Based on physicians perception of blood pressure response, the patient was either maintained on 4 mg or the dose was increased to 8 mg for an additional 6 weeks. From baseline to week 12, the mean sitting blood pressure significantly declined from 156.9/94.5 mm Hg to 139.2/84.0 mm Hg. Further dose titration resulted in a clinically significant reduction in blood pressure in all patients with inadequate response on 4 mg at week 6. Blood pressure control (<140/<90 mm Hg) was achieved at 12 weeks in 48.8% patients. The subpopulation analyses demonstrated that perindopril monotherapy was effective in both men and women, in patients of all ethnicities, and in patients <65 and > or =65 years of age. Perindopril was safe and well tolerated in all hypertensive subgroups including high-risk patients. Physicians were more attuned to controlling diastolic than systolic blood pressure, and their adherence to the treatment guidelines was found to be not optimal.
No takes yet. Share an insight, caveat, or question.
Julius et al. (2004) studied Hypertension (n=13,220). Perindopril was evaluated on Blood pressure control (<140/<90 mm Hg) at 12 weeks. Perindopril treatment for 12 weeks reduced mean sitting blood pressure from 156.9/94.5 to 139.2/84.0 mm Hg, with 48.8% of patients achieving blood pressure control.
Synapse has enriched 10 related papers. Consider them for comparative context: